Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Ayr Wellness Inc. stock logo
AYRWF
Ayr Wellness
$0.03
-4.9%
$0.13
$0.00
$2.60
$4.01M1.712.61 million shs983,319 shs
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
$1.57
+3.9%
$1.61
$1.12
$3.26
$15.46M2.07169,877 shs37,870 shs
Edesa Biotech, Inc. stock logo
EDSA
Edesa Biotech
$2.40
+0.8%
$2.19
$1.55
$5.00
$16.75M0.2720,798 shs27,900 shs
Mannatech, Incorporated stock logo
MTEX
Mannatech
$8.52
+0.2%
$8.68
$7.05
$16.49
$16.16M0.8421,327 shs6,051 shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Ayr Wellness Inc. stock logo
AYRWF
Ayr Wellness
-4.93%-16.54%-80.71%-85.80%-98.28%
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
+3.86%-7.67%-2.19%+7.19%-18.06%
Edesa Biotech, Inc. stock logo
EDSA
Edesa Biotech
+0.84%+7.62%+0.84%+22.45%-45.45%
Mannatech, Incorporated stock logo
MTEX
Mannatech
+0.18%-6.43%+5.05%-13.55%+21.64%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Ayr Wellness Inc. stock logo
AYRWF
Ayr Wellness
2.8646 of 5 stars
3.34.00.00.02.80.01.3
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
3.1104 of 5 stars
3.55.00.00.02.71.70.0
Edesa Biotech, Inc. stock logo
EDSA
Edesa Biotech
1.6095 of 5 stars
2.05.00.00.00.71.70.6
Mannatech, Incorporated stock logo
MTEX
Mannatech
0.4434 of 5 stars
0.03.00.00.01.51.70.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Ayr Wellness Inc. stock logo
AYRWF
Ayr Wellness
2.50
Moderate Buy$3.009,046.34% Upside
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
3.00
Buy$6.00283.39% Upside
Edesa Biotech, Inc. stock logo
EDSA
Edesa Biotech
4.00
Strong Buy$5.00108.33% Upside
Mannatech, Incorporated stock logo
MTEX
Mannatech
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest AYRWF, MTEX, COCP, and EDSA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/27/2025
Edesa Biotech, Inc. stock logo
EDSA
Edesa Biotech
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy$5.00
6/20/2025
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$7.00 ➝ $6.00
(Data available from 8/23/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Ayr Wellness Inc. stock logo
AYRWF
Ayr Wellness
$463.63M0.01N/AN/A$3.14 per share0.01
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
N/AN/AN/AN/A$0.52 per shareN/A
Edesa Biotech, Inc. stock logo
EDSA
Edesa Biotech
N/AN/AN/AN/A$0.70 per shareN/A
Mannatech, Incorporated stock logo
MTEX
Mannatech
$117.87M0.14$2.14 per share3.98$3.14 per share2.71
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Ayr Wellness Inc. stock logo
AYRWF
Ayr Wellness
-$359.31M-$3.26N/AN/AN/A-77.50%-31.73%-11.73%N/A
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
-$17.50M-$1.24N/AN/AN/AN/A-144.12%-102.85%N/A
Edesa Biotech, Inc. stock logo
EDSA
Edesa Biotech
-$6.17M-$1.32N/AN/AN/AN/A-162.95%-60.33%N/A
Mannatech, Incorporated stock logo
MTEX
Mannatech
$2.49M-$2.04N/AN/A-3.46%-48.60%-10.70%11/10/2025 (Estimated)

Latest AYRWF, MTEX, COCP, and EDSA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
-$0.30-$0.20+$0.10-$0.20N/AN/A
8/12/2025Q2 2025
Mannatech, Incorporated stock logo
MTEX
Mannatech
N/A-$2.27N/A-$2.27N/A$25.68 million
8/8/2025Q3 2025
Edesa Biotech, Inc. stock logo
EDSA
Edesa Biotech
-$0.26-$0.25+$0.01-$0.25N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Ayr Wellness Inc. stock logo
AYRWF
Ayr Wellness
N/AN/AN/AN/AN/A
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
N/AN/AN/AN/AN/A
Edesa Biotech, Inc. stock logo
EDSA
Edesa Biotech
N/AN/AN/AN/AN/A
Mannatech, Incorporated stock logo
MTEX
Mannatech
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Ayr Wellness Inc. stock logo
AYRWF
Ayr Wellness
1.10
1.60
0.57
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
N/A
3.69
4.57
Edesa Biotech, Inc. stock logo
EDSA
Edesa Biotech
N/A
18.96
18.96
Mannatech, Incorporated stock logo
MTEX
Mannatech
0.58
1.11
0.49

Institutional Ownership

CompanyInstitutional Ownership
Ayr Wellness Inc. stock logo
AYRWF
Ayr Wellness
0.91%
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
6.72%
Edesa Biotech, Inc. stock logo
EDSA
Edesa Biotech
5.50%
Mannatech, Incorporated stock logo
MTEX
Mannatech
12.98%

Insider Ownership

CompanyInsider Ownership
Ayr Wellness Inc. stock logo
AYRWF
Ayr Wellness
8.10%
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
28.14%
Edesa Biotech, Inc. stock logo
EDSA
Edesa Biotech
22.60%
Mannatech, Incorporated stock logo
MTEX
Mannatech
41.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Ayr Wellness Inc. stock logo
AYRWF
Ayr Wellness
2,440116.19 million106.77 millionNot Optionable
Cocrystal Pharma, Inc. stock logo
COCP
Cocrystal Pharma
1010.26 million7.37 millionNot Optionable
Edesa Biotech, Inc. stock logo
EDSA
Edesa Biotech
207.04 million5.45 millionNot Optionable
Mannatech, Incorporated stock logo
MTEX
Mannatech
2501.90 million1.11 millionNot Optionable

Recent News About These Companies

Mannatech, Incorporated (MTEX) - Yahoo Finance
Mannatech appoints Peter Griscom COO
Mannatech Reports Fourth Quarter 2024 Financial Results
Mannatech names Robert Toth vice chairman of the board
Mannatech Inc. Q3 Earnings Summary
Mannatech Reports Financial Results for Third Quarter 2024
Trading (MTEX) With Integrated Risk Controls
(MTEX) Investment Analysis

New MarketBeat Followers Over Time

Media Sentiment Over Time

Ayr Wellness stock logo

Ayr Wellness OTCMKTS:AYRWF

$0.03 0.00 (-4.93%)
As of 08/22/2025 03:56 PM Eastern

Ayr Wellness Inc. operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names. The company was formerly known as Ayr Strategies Inc. and changed its name to Ayr Wellness Inc. in February 2021. Ayr Wellness Inc. was incorporated in 2017 and is headquartered in Miami, Florida.

Cocrystal Pharma stock logo

Cocrystal Pharma NASDAQ:COCP

$1.56 +0.06 (+3.86%)
Closing price 08/22/2025 03:48 PM Eastern
Extended Trading
$1.56 0.00 (-0.32%)
As of 08/22/2025 05:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, norovirus, and respiratory virus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that has completed Phase I clinical trial for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp. to discover and develop proprietary influenza A/B antiviral agents; and a license agreement with Kansas State University Research Foundation to develop antiviral compounds for the treatment of norovirus and coronavirus infections. The company is headquartered in Bothell, Washington.

Edesa Biotech stock logo

Edesa Biotech NASDAQ:EDSA

$2.40 +0.02 (+0.84%)
Closing price 08/22/2025 03:51 PM Eastern
Extended Trading
$2.28 -0.12 (-5.17%)
As of 08/22/2025 07:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Edesa Biotech, Inc., a clinical-stage biopharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products for inflammatory and immune-related diseases. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress syndrome in Covid-19 patients; and EB01, a topical vanishing cream containing non-steroidal anti-inflammatory compound that has completed Phase 2b clinical study to treat chronic allergic contact dermatitis. The company also develops EB02, an extension of secretory phospholipase 2 anti-inflammatory cream for treating erythema, swelling, and exudation associated with hemorrhoids disease; and EB06, an anti- chemokine ligand 10 (CXCL10) monoclonal antibody in vitiligo. It has a collaboration agreement with NovImmune SA to develop monoclonal antibodies targeting products containing toll-like receptor 4 and CXCL10 for therapeutic, prophylactic, and diagnostic applications in humans and animals; and Yissum Research Development Company for the development of products for therapeutic, prophylactic, and diagnostic uses in topical dermal and anorectal applications, as well as for the use in dermatologic and gastrointestinal conditions. The company was founded in 2015 and is headquartered in Markham, Canada.

Mannatech stock logo

Mannatech NASDAQ:MTEX

$8.52 +0.02 (+0.18%)
Closing price 08/22/2025 03:45 PM Eastern
Extended Trading
$8.48 -0.04 (-0.47%)
As of 08/22/2025 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was incorporated in 1993 and is headquartered in Flower Mound, Texas.